Biomarkers such as granulysin, which is highly expressed in blister fluid and serum, correlate with BSA involvement and have 80% sensitivity and 95.7% specificity for early diagnosis, with serum granulysin potentially predicting SJS-TEN 2–4 days before skin detachment. The gene discussed is GNLY; the disease is Schwartz-Jampel syndrome.